ATF1 and central nervous system cancer: Interestingly, a single case of atypical central neurocytoma with EWSR1::ATF1 fusion and MUTYH G382D mutation (detected via NGS) achieved ~3 years of PFS with conventional glioma therapy in a 13-year-old patient (13).